Additional Metadata
Keywords Cardiovascular disease, Dyslipidaemia guidelines, Epidemiology, Evidence, Primary prevention, Statin
Persistent URL dx.doi.org/10.1016/j.atherosclerosis.2020.02.020, hdl.handle.net/1765/126295
Journal Atherosclerosis
Citation
Pavlovic, J, Kavousi, M, Ikram, M.A, & Leening, M.J.G. (Maarten J.G.). (2020). Updated treatment thresholds in the 2019 ESC/EAS dyslipidaemia guidelines substantially expand indications for statin use for primary prevention at population level: Results from the Rotterdam Study. Atherosclerosis, 299, 64–66. doi:10.1016/j.atherosclerosis.2020.02.020